The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 4, Issue 1, 1998, Pages 18-26

  Satsangi, Jack ^a   Landers, Carol J ^b   Welsh, Ken I ^c   Koss, Konrad ^a,c   Targan, Stephan ^b   Jewell, Derek P ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Anti neutrophil cytoplasmic antibodies; Crohn's disease; Genetic heterogeneity; Major histocompatibility complex.; Ulcerative colitis

Indexed keywords

HLA ANTIGEN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ARTICLE; CROHN DISEASE; DNA PROBE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC HETEROGENEITY; GENETIC MARKER; GENETICS; GENOTYPE; HUMAN; IMMUNOLOGY; MALE; POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; COLITIS, ULCERATIVE; CROHN DISEASE; DNA PROBES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC HETEROGENEITY; GENETIC MARKERS; GENOTYPE; HLA ANTIGENS; HUMANS; MALE; POLYMERASE CHAIN REACTION;

EID: 0031990645     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-199802000-00004     Document Type: Article

References (38)

1. Satsangi J, Rosenberg WMC, Jewell DP. The prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. Eur J Gastro Hepatol 1994;6:413-6.
2. Tysk C, Lindberg E, Järnerot G, Flodérus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins: a study of heritability and the influence of smoking. Gut 1988;29:990-6.
3. Satsangi J, Jewell DP, Rosenberg WMC, Bell JI. Genetics of inflammatory bowel disease. Gut 1994;35:696-700.
4. Satsangi J, Parkes M, Louis E, et al. Two-stage genome-wide search in inflammatory bowel disease: evidence for susceptibility loci on chromosomes 3, 7 and 12. Nature Genetics 1996;14:199-202.
5. Satsangi J, Jewell DP, Bell JI. Leading article: the genetics of inflammatory bowel disease. Gut 1997;40:572-3.
6. Futami S, Aoyama N, Honsako Y, et al. HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression. Dig Dis Sci 1995;40:814-8.
7. Toyoda H, Wang S-J, Yang H, et al. Distinct association of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993;104:741-8.
8. Satsangi J, Welsh KI, Bunce M, et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996;347: 1212-7.
9. Roussomoustakaki M, Satsangi J, Welsh KI, et al. Genetic markers may predict disease behaviour in patients with ulcerative colitis. Gastroenterology 1997;112:1845-53.
10. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis: comparison with other colitides/diarrhoeal illnesses. Gastroenterology 1992;100:1590-6.
11. Shanahan F, Duerr R, Rotter JI, Yang H, Sutherland LR, et al. Neutrophil auto-antibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 1992;103:456-61.
12. Yang H, Rotter JI, Toyoda H, et al. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest 1993;92:1080-4.
13. Seibold F, Slametschka D, Gregor M, Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1994;107:532-6.
14. Lee JC, Lennard-Jones JE, Cambridge G. Antineutrophil antibodies in familial inflammatory bowel disease. Gastroenterology 1995;108:428-33.
15. Bansi D, Lo SK, Chapman RWG, Fleming KA. Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis. Eur J Gastro Hepatol 1996;8:111-7.
16. Duerr RH, Neigut DA. Molecularly defined HLA-DR2 alleles in ulcerative colitis and an anti-neutrophil cytoplasmic antibody-positive subgroup. Gastroenterology 1995;108:423-7.
17. Vasiliauskas EA, Plevy SE, Landers CJ, et al. Peri-nuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology 1996;110:1810-9.
18. Jamar-Leclero N, Reumaux D, Duthilleul P, Colombel JF. Do p-ANCA define a clinical sub-group in patients with Crohn's disease? Gastroenterology 1997;112:316-7.
19. Miller S, Dykes D, Polesky H. A salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16: 1215.
20. Bunce M, Taylor CJ, Welsh KI. Rapid HLA-DBQ typing by eight PCR amplifications with sequence-specific primers (PCR-SSP). Hum Immunol 1993;37:201-6.
21. Olerup O, Zetterquist H. HLA-DR typing by PCR amplifications with sequence-specific primers in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39: 225-35.
22. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW. An allelic polymorphism within the human tumour necrosis factor-alpha promoter region is strongly associated with HLA A1, B8 and DR3 alleles. J Exp Med 1993;177:557-60.
23. Verjans GMGM, Brinkman BMN, van Doornik CEM, Kijlstra A, Verweij CL. Polymorphism of tumour necrosis factor-a (TNF-a) at position -308 in relation to ankylosing spondylitis. Clin Exp Immunol 1994;97:45-7.
24. Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990;86: 202-10.
25. Wallington TB, Gooi HC. Non-organ specific antibodies. In: Gooi HC, Chapel H, ed. Clinical immunology: a practical approach. Oxford: IRL Press, Oxford University Press, 1990:195-220.
26. Louis E, Satsangi J, Roussmoustakaki M, et al. Cytokine gene polymorphisms in inflammatory bowel disease. Gut 1996;39:705-10.
27. Chapman RW. Aetiology and natural history of primary sclerosing cholangitis: a decade of progress? Gut 1991;32:1433-5.
28. Mulder AHL, Broekroelofs J, Horst G, Limburg PC, Nelis GF, Kallenberg CGM. Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterisation and clinical correlates. Clin Exp Immunol 1994;95:490-7.
29. Aitola P, Miettinen A, Mattila A, Matikainen M, Soppi E. Effect of proctocolectomy on serum antineutrophil cytoplasmic antibodies in patients with chronic ulcerative colitis. J Clin Pathol 1995;48: 645-7.
30. Lindgren S, Floren CH, Lindhagen T, Starck M, Stewenius J, Nassberger L. Low prevalence of anti-neutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission. Eur J Gastro Hepatol 1995;7:563-8.
31. Satsangi J, Jewell DP. Leading article: are cytokine gene polymorphisms important in the pathogenesis of inflammatory bowel disease? Eur J Gastro Hepatol 1996;8:97-9.
32. Schumacher G, Kollberg B, Sandstedt B, Ljungh A, Nassberger L. Circulating granulocyte antibodies in first attacks of colitis. Scand J Gastroenterol 1995;30:157-63.
33. Hertervig E, Wieslander J, Johansson C, Wiik A, Nilsson A. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Scand J Gastroenterol 1995;30:693-8.
34. Targan SR, Landers CJ, Cobb L, MacDermott RP, Vidrich A. Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients. J Immunol 1995;155:3262-7.
35. Dignass A, Goebell H. Genetics of inflammatory bowel disease. Curr Opin Gastroenterol 1995;11:292-7.
36. Billing P, Tahir S, Calfin B, et al. Nuclear localisation of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies. Am J Pathol 1995;147:979-87.
37. Eggena MP, Targan SR, Vidrich A, Clemons DF, Iwancyzk L, Braun J. Histone H1: the UC-specific pANCA target antigen FASEB J 1996;10:463.
38. Sobajima J, Ozaki S, Osakada K, et al. Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis: non-histone chromosomal proteins (HMG1 and HMG2). Clin Exp Immunol 1997;107:135-41.